Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

ID JAX:10000003
Name Advanced Solid Tumor
Definition β€œAn abnormal mass of tissue that usually does not contain cysts or liquid areas. Different types of solid tumors are named for the type of cells that form them. Examples of solid tumors are sarcomas, carcinomas, and lymphomas). ”
Source The Jackson Laboratory (a custom term added that does not corresond to an existing term in the disease ontology)
Alt Ids
Path Advanced Solid Tumor

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
PIK3CA mutant CUDC-907 Advanced Solid Tumor sensitive detail...
PIK3CA wild-type PX-866 Advanced Solid Tumor sensitive detail...
PIK3CA mutant PX-866 Advanced Solid Tumor sensitive detail...
TP53 mutant Bevacizumab Advanced Solid Tumor sensitive detail...
FGFR2 act mut Debio 1347 Advanced Solid Tumor sensitive detail...
PIK3CA act mut Taselisib Advanced Solid Tumor conflicting detail...
PIK3CA mutant M2698 Advanced Solid Tumor sensitive detail...
TP53 positive MVAp53 Advanced Solid Tumor sensitive detail...
BRAF V600E PLX8394 Advanced Solid Tumor sensitive detail...
BRAF L597R Trametinib Advanced Solid Tumor sensitive detail...
BRAF L597R Vemurafenib Advanced Solid Tumor sensitive detail...
BRAF L597S Vemurafenib Advanced Solid Tumor sensitive detail...
BRAF L597S Trametinib Advanced Solid Tumor sensitive detail...
BRAF K601E Trametinib Advanced Solid Tumor sensitive detail...
BRAF K601E Vemurafenib Advanced Solid Tumor conflicting detail...
BRAF mutant Dabrafenib Advanced Solid Tumor sensitive detail...
TP53 wild-type Pazopanib + Vorinostat Advanced Solid Tumor decreased response detail...
RET mutant Ponatinib Advanced Solid Tumor sensitive detail...
BRAF act mut Binimetinib + Encorafenib Advanced Solid Tumor sensitive detail...
BRAF act mut PLX8394 Advanced Solid Tumor sensitive detail...
FGFR3 R248C Vofatamab Advanced Solid Tumor sensitive detail...
FGFR3 S249C Vofatamab Advanced Solid Tumor sensitive detail...
FGFR3 G372C Vofatamab Advanced Solid Tumor sensitive detail...
FGFR3 Y375C Vofatamab Advanced Solid Tumor sensitive detail...
FGFR3 K652E Vofatamab Advanced Solid Tumor sensitive detail...
FGFR3 mutant Infigratinib Advanced Solid Tumor sensitive detail...
TP53 loss Adavosertib Advanced Solid Tumor sensitive detail...
PTEN negative Talazoparib Advanced Solid Tumor conflicting detail...
PIK3CA mutant XL147 Advanced Solid Tumor sensitive detail...
RET G691S Dovitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 act mut Debio 1347 Advanced Solid Tumor sensitive detail...
FGFR3 act mut Debio 1347 Advanced Solid Tumor sensitive detail...
PIK3CA act mut BAY1125976 Advanced Solid Tumor sensitive detail...
PTEN loss BAY1125976 Advanced Solid Tumor sensitive detail...
PIK3CA act mut Everolimus Advanced Solid Tumor sensitive detail...
PIK3CA E542K Sirolimus Advanced Solid Tumor sensitive detail...
PIK3CA act mut Metformin Advanced Solid Tumor sensitive detail...
PIK3CA E545K Sirolimus Advanced Solid Tumor sensitive detail...
PIK3CA E545K Alpelisib Advanced Solid Tumor sensitive detail...
PIK3CA mutant Onatasertib Advanced Solid Tumor sensitive detail...
PIK3CA act mut Ipatasertib + Paclitaxel Advanced Solid Tumor sensitive detail...
PIK3CA act mut Afuresertib Advanced Solid Tumor sensitive detail...
RAD51D loss Olaparib Advanced Solid Tumor sensitive detail...
JAK3 V722I Tofacitinib Advanced Solid Tumor sensitive detail...
PIK3CA C420R Sirolimus Advanced Solid Tumor sensitive detail...
PIK3CA mutant Alpelisib Advanced Solid Tumor sensitive detail...
PIK3CA mutant Carboxyamidotriazole Orotate Advanced Solid Tumor sensitive detail...
PIK3CA mutant MLN1117 Advanced Solid Tumor sensitive detail...
PIK3CA mutant VS-5584 Advanced Solid Tumor sensitive detail...
RB1 positive Ribociclib Advanced Solid Tumor predicted - sensitive detail...
HRAS G12V Cetuximab Advanced Solid Tumor resistant detail...
HRAS G12V Panitumumab Advanced Solid Tumor resistant detail...
FLT3 D835Y Midostaurin Advanced Solid Tumor sensitive detail...
RET S891A Sorafenib Advanced Solid Tumor sensitive detail...
RET M918T Sorafenib Advanced Solid Tumor sensitive detail...
RET C634R Sorafenib Advanced Solid Tumor sensitive detail...
BRAF mutant Obatoclax Advanced Solid Tumor sensitive detail...
NRAS mutant Obatoclax Advanced Solid Tumor sensitive detail...
RET C634R Ponatinib Advanced Solid Tumor sensitive detail...
RET V804L Ponatinib Advanced Solid Tumor sensitive detail...
RET V804M Ponatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T Ceritinib Advanced Solid Tumor sensitive detail...
PIK3CA mutant Sapanisertib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y Ensartinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M Ensartinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK S1206Y Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1152R Crizotinib Advanced Solid Tumor resistant detail...
RET V804M Sorafenib Advanced Solid Tumor sensitive detail...
FLT3 Y572C Midostaurin Advanced Solid Tumor sensitive detail...
FLT3 S451F Midostaurin Advanced Solid Tumor decreased response detail...
FLT3 V592G Midostaurin Advanced Solid Tumor sensitive detail...
FLT3 R834Q Midostaurin Advanced Solid Tumor sensitive detail...
FLT3 R834Q PD98059 Advanced Solid Tumor sensitive detail...
PIK3CA M1043V Sirolimus Advanced Solid Tumor sensitive detail...
PIK3CA mutant BAY1082439 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D839G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 Y842C Pexidartinib Advanced Solid Tumor resistant detail...
FGFR3 amp Ponatinib Advanced Solid Tumor predicted - sensitive detail...
SMARCA4 loss N/A Advanced Solid Tumor not applicable detail...
KIT V560D Sorafenib Advanced Solid Tumor sensitive detail...
KIT V560D Dasatinib Advanced Solid Tumor sensitive detail...
KIT V560G Nilotinib Advanced Solid Tumor sensitive detail...
FGFR2 N550K Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 N550S Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 N550H Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 V565I Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 E566G Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 L618M Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 K660E Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 I548V Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 M538I Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 M536I Dovitinib Advanced Solid Tumor decreased response detail...
FGFR2 N550H PD173074 Advanced Solid Tumor resistant detail...
FGFR2 E566G PD173074 Advanced Solid Tumor resistant detail...
FGFR2 M536I PD173074 Advanced Solid Tumor decreased response detail...
FGFR2 M538I PD173074 Advanced Solid Tumor decreased response detail...
FGFR2 I548V PD173074 Advanced Solid Tumor decreased response detail...
FGFR2 N550S PD173074 Advanced Solid Tumor decreased response detail...
FGFR2 L618M PD173074 Advanced Solid Tumor decreased response detail...
FGFR2 V565I Ponatinib Advanced Solid Tumor resistant detail...
FGFR2 M538I Ponatinib Advanced Solid Tumor decreased response detail...
FGFR2 K660E Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 M536I Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 I548V Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 N550H Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 N550K Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 N550S Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 E566G Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 S267_D273dup Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 W290_I291delinsC Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 - TACC3 Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 S267_D273dup Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 W290_I291delinsC Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 - TACC3 Ponatinib Advanced Solid Tumor sensitive detail...
PIK3CA mutant A-443654 Advanced Solid Tumor sensitive detail...
PIK3CA E545K A66 Advanced Solid Tumor resistant detail...
PIK3CA H1047R A66 Advanced Solid Tumor sensitive detail...
PIK3CA mutant AT-7867 Advanced Solid Tumor sensitive detail...
PIK3CA mutant Taselisib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y Alectinib Advanced Solid Tumor sensitive detail...
ARID1B dec exp Cisplatin Advanced Solid Tumor sensitive detail...
ALK C1156Y Alectinib Advanced Solid Tumor sensitive detail...
RET Y806C Ponatinib Advanced Solid Tumor sensitive detail...
RET A883F Ponatinib Advanced Solid Tumor sensitive detail...
RET Y791F Ponatinib Advanced Solid Tumor sensitive detail...
RET E768D Ponatinib Advanced Solid Tumor sensitive detail...
RET L790F Ponatinib Advanced Solid Tumor sensitive detail...
RET D898V Ponatinib Advanced Solid Tumor sensitive detail...
RET M918T Ponatinib Advanced Solid Tumor sensitive detail...
RET C634Y Ponatinib Advanced Solid Tumor sensitive detail...
RET E884K Ponatinib Advanced Solid Tumor sensitive detail...
RET S891A Ponatinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins Midostaurin Advanced Solid Tumor sensitive detail...
FLT3 wild-type Midostaurin Advanced Solid Tumor sensitive detail...
FGFR2 S252W Dovitinib Advanced Solid Tumor conflicting detail...
FGFR2 N550K PD173074 Advanced Solid Tumor resistant detail...
FGFR2 V565I PD173074 Advanced Solid Tumor resistant detail...
FGFR2 L618M Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 K660E PD173074 Advanced Solid Tumor decreased response detail...
PIK3CA mutant Bevacizumab + Pegylated liposomal-doxorubicin + Temsirolimus Advanced Solid Tumor sensitive detail...
FBXW7 inact mut Entinostat Advanced Solid Tumor sensitive detail...
FBXW7 inact mut Docetaxel Advanced Solid Tumor resistant detail...
FBXW7 inact mut Belinostat Advanced Solid Tumor sensitive detail...
FBXW7 inact mut AR-42 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171T Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK V1180L TAE684 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T TAE684 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T Brigatinib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ASP3026 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L ASP3026 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T ASP3026 Advanced Solid Tumor resistant detail...
TP53 mutant Pazopanib + Vorinostat Advanced Solid Tumor sensitive detail...
RET E768D Vandetanib Advanced Solid Tumor sensitive detail...
RET L790F Vandetanib Advanced Solid Tumor sensitive detail...
RET Y791F Vandetanib Advanced Solid Tumor sensitive detail...
RET S891A Vandetanib Advanced Solid Tumor sensitive detail...
RET M918T Vandetanib Advanced Solid Tumor sensitive detail...
RET A883F Vandetanib Advanced Solid Tumor sensitive detail...
RET V804L Vandetanib Advanced Solid Tumor resistant detail...
RET V804M Vandetanib Advanced Solid Tumor resistant detail...
RET C634R Vandetanib Advanced Solid Tumor sensitive detail...
RET C634R RET V804G Vandetanib Advanced Solid Tumor sensitive detail...
FGFR1 act mut Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 act mut Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 act mut Ponatinib Advanced Solid Tumor sensitive detail...
FGFR1 act mut Dovitinib Advanced Solid Tumor sensitive detail...
FGFR2 act mut Dovitinib Advanced Solid Tumor sensitive detail...
FGFR3 act mut Dovitinib Advanced Solid Tumor sensitive detail...
FGFR1 act mut Cediranib Advanced Solid Tumor decreased response detail...
FGFR2 act mut Cediranib Advanced Solid Tumor decreased response detail...
FGFR3 act mut Cediranib Advanced Solid Tumor decreased response detail...
FGFR1 act mut Nintedanib Advanced Solid Tumor decreased response detail...
FGFR2 act mut Nintedanib Advanced Solid Tumor decreased response detail...
FGFR3 act mut Nintedanib Advanced Solid Tumor decreased response detail...
FGFR2 act mut Brivanib Advanced Solid Tumor decreased response detail...
FGFR1 act mut Brivanib Advanced Solid Tumor no benefit detail...
FGFR3 act mut Brivanib Advanced Solid Tumor no benefit detail...
KIT D816V Ponatinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins Cabozantinib Advanced Solid Tumor predicted - sensitive detail...
KIT D816V Sunitinib Advanced Solid Tumor resistant detail...
KIT D816V Nilotinib Advanced Solid Tumor decreased response detail...
KIT D816V Imatinib Advanced Solid Tumor resistant detail...
KIT D816V Cabozantinib Advanced Solid Tumor resistant detail...
KIT D816H Regorafenib Advanced Solid Tumor resistant detail...
KIT D816V Quizartinib Advanced Solid Tumor resistant detail...
RET rearrange RXDX-105 Advanced Solid Tumor sensitive detail...
PTEN del GSK2636771 Advanced Solid Tumor no benefit detail...
PIK3CA mutant AZD8835 Advanced Solid Tumor sensitive detail...
PIK3CA mutant Uprosertib Advanced Solid Tumor predicted - sensitive detail...
RB1 loss Palbociclib Advanced Solid Tumor no benefit detail...
TP53 R175H ReACp53 Advanced Solid Tumor sensitive detail...
FGFR2 wild-type AZ6089 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 over exp LY2874455 Advanced Solid Tumor sensitive detail...
FGFR3 K650E PD98059 Advanced Solid Tumor sensitive detail...
FGFR1 act mut Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 act mut Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 act mut Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 fusion Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 V561M FIIN-1 Advanced Solid Tumor sensitive detail...
FGFR1 fusion Dovitinib Advanced Solid Tumor sensitive detail...
FGFR2 - AHCYL1 Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 - AHCYL1 PD173074 Advanced Solid Tumor sensitive detail...
FGFR2 - BICC1 Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 - BICC1 PD173074 Advanced Solid Tumor sensitive detail...
PIK3CA Q546K Trametinib Advanced Solid Tumor sensitive detail...
PIK3CA N345K Trametinib Advanced Solid Tumor sensitive detail...
PIK3CA H1047R Trametinib Advanced Solid Tumor sensitive detail...
PIK3CA G1049R Trametinib Advanced Solid Tumor sensitive detail...
PIK3CA E545K Trametinib Advanced Solid Tumor sensitive detail...
KIT H697Y Sunitinib Advanced Solid Tumor sensitive detail...
KIT H697Y Imatinib Advanced Solid Tumor decreased response detail...
KIT V560del Imatinib Advanced Solid Tumor sensitive detail...
KIT V560del Sunitinib Advanced Solid Tumor sensitive detail...
PTEN del Onatasertib Advanced Solid Tumor sensitive detail...
CSF3R T640N Ruxolitinib Advanced Solid Tumor sensitive detail...
CSF3R T618I Ruxolitinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins Pexidartinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 F691L Pexidartinib Advanced Solid Tumor sensitive detail...
FLT3 D835V Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835Y Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835V Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835F Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 Y842H Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 M664I Pexidartinib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 M664I FLT3 F691L Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N676S Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N676S FLT3 F691L Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D698N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D698N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 R834Q Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 R834Q Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835E Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D835E Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D835G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D835H Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835H Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D835N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D835N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D835Y Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D839A Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D839A Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D839G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D839H Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 D839N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 D839N Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N841K Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 N841K Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 Y842C Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 Y842H Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 Y842S Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 Y842S Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 R845G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 R845G Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 G846R Pexidartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L FLT3 G846R Pexidartinib Advanced Solid Tumor resistant detail...
PTEN dec exp GSK2636771 Advanced Solid Tumor sensitive detail...
TP53 R248Q Ganetespib Advanced Solid Tumor sensitive detail...
TP53 R175H Alvespimycin + Vorinostat Advanced Solid Tumor sensitive detail...
FLT3 D835Y Pexidartinib Advanced Solid Tumor resistant detail...
PTEN loss SAR260301 Advanced Solid Tumor no benefit detail...
RET C634Y HG-6-63-01 Advanced Solid Tumor sensitive detail...
RET C634Y XMD15-44 Advanced Solid Tumor sensitive detail...
RET C634Y ALW-II-41-27 Advanced Solid Tumor sensitive detail...
RET M918T HG-6-63-01 Advanced Solid Tumor sensitive detail...
RET M918T XMD15-44 Advanced Solid Tumor sensitive detail...
RET M918T ALW-II-41-27 Advanced Solid Tumor sensitive detail...
PIK3CA mutant GDC-0980 Advanced Solid Tumor sensitive detail...
PIK3CA act mut GSK1059615 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171S Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S Ceritinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK I1171S Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S Brigatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK I1171S ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S AZD3463 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L Crizotinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK F1174L Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174L Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L AZD3463 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK R1192P Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK R1192P Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK R1192P Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK R1192P Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK R1192P ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK R1192P AZD3463 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151M Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151M Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151M Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151M AZD3463 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151M Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK T1151M ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1269A Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK G1269A ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1269A AZD3463 Advanced Solid Tumor sensitive detail...
ATM loss YU238259 Advanced Solid Tumor sensitive detail...
TP53 wild-type CTX-1 Advanced Solid Tumor sensitive detail...
TP53 loss CTX-1 Advanced Solid Tumor decreased response detail...
TP53 mutant CTX-1 Advanced Solid Tumor sensitive detail...
TP53 wild-type CTX-1 + Nutlin-3a Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y Entrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M Entrectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK G1202R Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Entrectinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK L1198F Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ALK L1198F Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ALK L1198F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F Lorlatinib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK C1156Y ALK L1198F Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y Ceritinib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198F Ceritinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK C1156Y ALK L1198F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK L1198F Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C ALK L1198F Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C ALK L1198F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C ALK L1198F Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C Ceritinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK F1174C ALK L1198F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK F1174C ALK L1198F Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK L1196M Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M ALK L1198F Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK L1198F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK L1198F Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK L1198F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK L1198F Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M Lorlatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK G1202R Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1202R Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1202R Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1202R Brigatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK L1198F ALK G1202R Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F ALK G1202R Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1202R Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1202R Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1202R Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F ALK G1269A Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1269A Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1269A Alectinib Advanced Solid Tumor resistant detail...
JAK2 V617F Ruxolitinib + ZSTK474 Advanced Solid Tumor sensitive detail...
JAK2 over exp Ruxolitinib + ZSTK474 Advanced Solid Tumor sensitive detail...
JAK2 over exp Pictilisib + Ruxolitinib Advanced Solid Tumor sensitive detail...
JAK2 V617F Pictilisib + Ruxolitinib Advanced Solid Tumor sensitive detail...
JAK2 over exp Dactolisib + Ruxolitinib Advanced Solid Tumor sensitive detail...
JAK2 V617F Dactolisib + Ruxolitinib Advanced Solid Tumor sensitive detail...
JAK2 V617F Ruxolitinib + TGX-221 Advanced Solid Tumor sensitive detail...
JAK2 over exp Ruxolitinib + TGX-221 Advanced Solid Tumor sensitive detail...
ALK wild-type Repotrectinib Advanced Solid Tumor sensitive detail...
ALK G1202R Repotrectinib Advanced Solid Tumor sensitive detail...
ALK L1196M Repotrectinib Advanced Solid Tumor sensitive detail...
ALK G1128A Brigatinib Advanced Solid Tumor sensitive detail...
ALK I1171N Brigatinib Advanced Solid Tumor sensitive detail...
ALK F1174L Brigatinib Advanced Solid Tumor sensitive detail...
ALK R1192P Brigatinib Advanced Solid Tumor sensitive detail...
ALK F1245C Brigatinib Advanced Solid Tumor sensitive detail...
ALK R1275Q Brigatinib Advanced Solid Tumor sensitive detail...
ALK Y1278S Brigatinib Advanced Solid Tumor sensitive detail...
ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
PIK3CA H1047R Sirolimus Advanced Solid Tumor sensitive detail...
PIK3CA E545K GDC-0980 Advanced Solid Tumor sensitive detail...
RET C634R Pz-1 Advanced Solid Tumor sensitive detail...
RET M918T Pz-1 Advanced Solid Tumor predicted - sensitive detail...
RET V804L Pz-1 Advanced Solid Tumor predicted - sensitive detail...
RET V804M Pz-1 Advanced Solid Tumor predicted - sensitive detail...
HRAS G12V Pz-1 Advanced Solid Tumor sensitive detail...
BRAF mutant XL147 Advanced Solid Tumor decreased response detail...
KIT act mut PLX9486 Advanced Solid Tumor sensitive detail...
ATM inact mut E7449 Advanced Solid Tumor sensitive detail...
RAD51C inact mut E7449 Advanced Solid Tumor sensitive detail...
ROS1 rearrange Entrectinib Advanced Solid Tumor sensitive detail...
ALK rearrange Entrectinib Advanced Solid Tumor sensitive detail...
KIT V654A Imatinib Advanced Solid Tumor resistant detail...
KIT V559D Ponatinib Advanced Solid Tumor sensitive detail...
KIT V560G Ponatinib Advanced Solid Tumor sensitive detail...
KIT T670I Ponatinib Advanced Solid Tumor sensitive detail...
KIT D816H Ponatinib Advanced Solid Tumor sensitive detail...
KIT D820E Ponatinib Advanced Solid Tumor sensitive detail...
KIT A829P Ponatinib Advanced Solid Tumor sensitive detail...
KIT V654A Ponatinib Advanced Solid Tumor sensitive detail...
KIT V560D Ponatinib Advanced Solid Tumor sensitive detail...
KIT V560D Sunitinib Advanced Solid Tumor sensitive detail...
KIT V560D Imatinib Advanced Solid Tumor sensitive detail...
KIT V560D Regorafenib Advanced Solid Tumor sensitive detail...
KIT exon9 Ponatinib Advanced Solid Tumor sensitive detail...
KIT exon9 Sunitinib Advanced Solid Tumor sensitive detail...
KIT exon9 Imatinib Advanced Solid Tumor resistant detail...
KIT exon9 Regorafenib Advanced Solid Tumor resistant detail...
KIT W557_K558del Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del Sunitinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del Imatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del Regorafenib Advanced Solid Tumor sensitive detail...
KIT P551_K558del Ponatinib Advanced Solid Tumor sensitive detail...
KIT P551_K558del Sunitinib Advanced Solid Tumor sensitive detail...
KIT P551_K558del Imatinib Advanced Solid Tumor sensitive detail...
KIT P551_K558del Regorafenib Advanced Solid Tumor sensitive detail...
KIT P551_E554del Ponatinib Advanced Solid Tumor sensitive detail...
KIT T417_D419delinsI Imatinib Advanced Solid Tumor conflicting detail...
KIT P551_E554del Sunitinib Advanced Solid Tumor resistant detail...
KIT P551_E554del Imatinib Advanced Solid Tumor resistant detail...
KIT P551_E554del Regorafenib Advanced Solid Tumor resistant detail...
KIT K558delinsNP Ponatinib Advanced Solid Tumor sensitive detail...
KIT K558delinsNP Sunitinib Advanced Solid Tumor sensitive detail...
KIT K558delinsNP Imatinib Advanced Solid Tumor sensitive detail...
KIT K558delinsNP Regorafenib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT V654A Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT V654A Sunitinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT V654A Imatinib Advanced Solid Tumor no benefit detail...
KIT W557_K558del KIT V654A Regorafenib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT T670I Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT T670I Sunitinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT T670I Imatinib Advanced Solid Tumor no benefit detail...
KIT W557_K558del KIT T670I Regorafenib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT D816H Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D816H Sunitinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT D816H Imatinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT D816H Regorafenib Advanced Solid Tumor decreased response detail...
BRAF T529I BRAF V600E SB590885 Advanced Solid Tumor predicted - resistant detail...
BRAF V600E SB590885 Advanced Solid Tumor sensitive detail...
BRAF T529M BRAF V600E SB590885 Advanced Solid Tumor predicted - resistant detail...
BRAF T529N BRAF V600E RAF265 Advanced Solid Tumor resistant detail...
BRAF T529I BRAF V600E RAF265 Advanced Solid Tumor predicted - sensitive detail...
BRAF T529M BRAF V600E RAF265 Advanced Solid Tumor predicted - sensitive detail...
BRAF V600E RAF265 Advanced Solid Tumor sensitive detail...
BRAF T529N BRAF V600E SB590885 Advanced Solid Tumor resistant detail...
BRAF T529M BRAF V600E PLX4720 Advanced Solid Tumor predicted - resistant detail...
BRAF T529I BRAF V600E PLX4720 Advanced Solid Tumor predicted - resistant detail...
BRAF V600E PLX4720 Advanced Solid Tumor sensitive detail...
BRAF T529N BRAF V600E PLX4720 Advanced Solid Tumor resistant detail...
BRAF T529N BRAF V600E Sorafenib Advanced Solid Tumor conflicting detail...
BRAF T529M BRAF V600E Sorafenib Advanced Solid Tumor predicted - sensitive detail...
BRAF T529I BRAF V600E Sorafenib Advanced Solid Tumor predicted - sensitive detail...
BRAF T529N BRAF V600E CI-1040 Advanced Solid Tumor sensitive detail...
BRAF T529M BRAF V600E CI-1040 Advanced Solid Tumor predicted - sensitive detail...
BRAF T529I BRAF V600E CI-1040 Advanced Solid Tumor sensitive detail...
BRAF V600E CI-1040 Advanced Solid Tumor sensitive detail...
KIT W557G Imatinib Advanced Solid Tumor sensitive detail...
KIT Y578C Imatinib Advanced Solid Tumor sensitive detail...
KIT W557C KIT Y578C Imatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D816G Ponatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820A Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D820G Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT N822K Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT A829P Ponatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D816G Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820A Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820G Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT N822K Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT A829P Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D816G Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820A Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820G Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT N822K Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT A829P Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D816G Regorafenib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT D820A Regorafenib Advanced Solid Tumor conflicting detail...
KIT W557_K558del KIT D820G Regorafenib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT N822K Regorafenib Advanced Solid Tumor conflicting detail...
KIT W557_K558del KIT A829P Regorafenib Advanced Solid Tumor conflicting detail...
FGFR1 mutant Pemigatinib Advanced Solid Tumor sensitive detail...
PTEN dec exp Pemetrexed Disodium + Sorafenib Advanced Solid Tumor predicted - sensitive detail...
JAK3 V674A Ruxolitinib Advanced Solid Tumor sensitive detail...
JAK3 L857P Ruxolitinib Advanced Solid Tumor decreased response detail...
JAK3 Y100A JAK3 L857P Ruxolitinib Advanced Solid Tumor decreased response detail...
JAK3 L857P NIBR3049 Advanced Solid Tumor sensitive detail...
JAK3 Y100A JAK3 L857P NIBR3049 Advanced Solid Tumor sensitive detail...
JAK3 V674A NIBR3049 Advanced Solid Tumor decreased response detail...
JAK3 V674A Tofacitinib Advanced Solid Tumor sensitive detail...
JAK3 L857P Tofacitinib Advanced Solid Tumor sensitive detail...
JAK3 Y100A JAK3 L857P Tofacitinib Advanced Solid Tumor sensitive detail...
FGFR3 K650E AZD4547 Advanced Solid Tumor decreased response detail...
FGFR3 N540K AZD4547 Advanced Solid Tumor resistant detail...
FGFR3 K650E Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR3 N540K Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR3 - TACC3 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR3 - TACC3 AZD4547 Advanced Solid Tumor sensitive detail...
BRAF V600E BGB-283 Advanced Solid Tumor sensitive detail...
BRAF wild-type BGB-283 Advanced Solid Tumor resistant detail...
TP53 mutant KRT-232 Advanced Solid Tumor resistant detail...
TP53 wild-type KRT-232 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1152R Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK S1206Y Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174L Lorlatinib Advanced Solid Tumor sensitive detail...
TP53 positive p28 Advanced Solid Tumor predicted - sensitive detail...
ALK R1275Q Lorlatinib Advanced Solid Tumor sensitive detail...
ALK F1174L Lorlatinib Advanced Solid Tumor sensitive detail...
ALK F1245C Lorlatinib Advanced Solid Tumor sensitive detail...
FGFR2 mutant Pemigatinib Advanced Solid Tumor sensitive detail...
FGFR3 mutant Pemigatinib Advanced Solid Tumor sensitive detail...
FGFR2 wild-type PRN1371 Advanced Solid Tumor sensitive detail...
FGFR2 K660E PRN1371 Advanced Solid Tumor sensitive detail...
FGFR2 K660N PRN1371 Advanced Solid Tumor sensitive detail...
FGFR2 N550K PRN1371 Advanced Solid Tumor sensitive detail...
FGFR3 over exp PRN1371 Advanced Solid Tumor sensitive detail...
FGFR3 K650M PRN1371 Advanced Solid Tumor sensitive detail...
ATM inact mut Veliparib Advanced Solid Tumor sensitive detail...
HRAS G12V Rigosertib Sodium Advanced Solid Tumor sensitive detail...
PIK3CA E545K Rigosertib Sodium Advanced Solid Tumor sensitive detail...
PIK3CA H1047R Rigosertib Sodium Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N Lorlatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK I1171S Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171T Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1202R Lorlatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK G1202del Crizotinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK G1202del Ceritinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK G1202del Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1202del Brigatinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK G1202del Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK D1203N Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK E1210K Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK E1210K Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK E1210K Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK E1210K Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C ALK D1203N Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C ALK D1203N Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C ALK D1203N Brigatinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK F1174C ALK D1203N Lorlatinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK D1203N ALK E1210K Crizotinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK D1203N ALK E1210K Ceritinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK D1203N ALK E1210K Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N ALK E1210K Brigatinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK D1203N ALK E1210K Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174C ALK D1203N Ceritinib Advanced Solid Tumor resistant detail...
KIT D816V BPR1J373 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 positive Aprutumab ixadotin Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins Brigatinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D835Y Brigatinib Advanced Solid Tumor sensitive detail...
ROS1 fusion Brigatinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 F691L Brigatinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 F691I Brigatinib Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK T1151dup Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1152R Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1152P Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174V Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK S1206F Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK S1206Y Brigatinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK T1151dup Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1152P Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174V Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK L1152R Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1152P Ceritinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N676D Midostaurin Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691I Midostaurin Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691I Sunitinib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 A848P Sunitinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691I Sorafenib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L Sorafenib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 A848P Sorafenib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 Y842H Sorafenib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 N676D Quizartinib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 Y842H Quizartinib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 A848P Quizartinib Advanced Solid Tumor decreased response detail...
FLT3 exon 14 ins FLT3 F691I Quizartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L Quizartinib Advanced Solid Tumor resistant detail...
TP53 mutant Adavosertib Advanced Solid Tumor predicted - sensitive detail...
TSC2 loss Buthionine sulfoximine + Sirolimus Advanced Solid Tumor sensitive detail...
BRAF G464E Vemurafenib Advanced Solid Tumor resistant detail...
BRAF G464V Vemurafenib Advanced Solid Tumor resistant detail...
BRAF G464R Vemurafenib Advanced Solid Tumor resistant detail...
BRAF G469A Vemurafenib Advanced Solid Tumor resistant detail...
BRAF G469V Vemurafenib Advanced Solid Tumor resistant detail...
BRAF L597V Vemurafenib Advanced Solid Tumor resistant detail...
BRAF L597Q Vemurafenib Advanced Solid Tumor resistant detail...
BRAF K601T Vemurafenib Advanced Solid Tumor resistant detail...
BRAF K601N Vemurafenib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 F691L MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D835Y MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 D835Y MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 D835V MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 Y842H MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 Y842C MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D835F MRX-2843 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D835V MRX-2843 Advanced Solid Tumor sensitive detail...
HRAS mutant Selumetinib Advanced Solid Tumor predicted - sensitive detail...
HRAS mutant Binimetinib Advanced Solid Tumor predicted - sensitive detail...
HRAS mutant Everolimus Advanced Solid Tumor predicted - sensitive detail...
HRAS Q61L Everolimus Advanced Solid Tumor sensitive detail...
HRAS Q61R Everolimus Advanced Solid Tumor sensitive detail...
HRAS G12V Everolimus Advanced Solid Tumor sensitive detail...
HRAS Q61R Binimetinib Advanced Solid Tumor sensitive detail...
HRAS Q61L Binimetinib Advanced Solid Tumor sensitive detail...
HRAS G12V Binimetinib Advanced Solid Tumor sensitive detail...
HRAS G12V Binimetinib + Everolimus Advanced Solid Tumor sensitive detail...
HRAS Q61L Binimetinib + Everolimus Advanced Solid Tumor sensitive detail...
BRAF mutant MLN2480 Advanced Solid Tumor predicted - sensitive detail...
NRAS G12D N-Arachidonoyl Dopamine Advanced Solid Tumor sensitive detail...
HRAS Q61L NS1 Advanced Solid Tumor sensitive detail...
NRAS G12D NS1 Advanced Solid Tumor no benefit detail...
PTEN inact mut Capivasertib Advanced Solid Tumor sensitive detail...
PTEN loss Capivasertib Advanced Solid Tumor sensitive detail...
IDH1 R132H Talazoparib Advanced Solid Tumor sensitive detail...
IDH1 R132H Berzosertib Advanced Solid Tumor sensitive detail...
IDH1 R132H Olaparib Advanced Solid Tumor sensitive detail...
IDH1 R132H Niraparib Advanced Solid Tumor sensitive detail...
IDH1 R132H Rucaparib Advanced Solid Tumor sensitive detail...
IDH1 R132H Cisplatin + Talazoparib Advanced Solid Tumor sensitive detail...
IDH1 R132H AGI-5198 + Talazoparib Advanced Solid Tumor decreased response detail...
TP53 wild-type HDM201 Advanced Solid Tumor sensitive detail...
FGFR3 L608V Infigratinib Advanced Solid Tumor decreased response detail...
FGFR3 K650E Infigratinib Advanced Solid Tumor decreased response detail...
FGFR3 N540K Infigratinib Advanced Solid Tumor resistant detail...
FGFR3 V555L Infigratinib Advanced Solid Tumor decreased response detail...
FGFR3 V555M Infigratinib Advanced Solid Tumor resistant detail...
FGFR3 L608V Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 V555M Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 N540K Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 K650E Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 K650E Dovitinib Advanced Solid Tumor conflicting detail...
FGFR3 N540K Dovitinib Advanced Solid Tumor sensitive detail...
FGFR3 V555M Dovitinib Advanced Solid Tumor sensitive detail...
FGFR3 L608V Dovitinib Advanced Solid Tumor sensitive detail...
FGFR3 L608V AZD4547 Advanced Solid Tumor decreased response detail...
FGFR3 V555M AZD4547 Advanced Solid Tumor resistant detail...
FGFR3 L608V Debio 1347 Advanced Solid Tumor decreased response detail...
FGFR3 V555M Debio 1347 Advanced Solid Tumor decreased response detail...
FGFR3 N540K Debio 1347 Advanced Solid Tumor decreased response detail...
FGFR3 K650E Debio 1347 Advanced Solid Tumor sensitive detail...
FGFR3 L608V FIIN-2 Advanced Solid Tumor sensitive detail...
FGFR3 K650E FIIN-2 Advanced Solid Tumor sensitive detail...
FGFR3 V555M FIIN-2 Advanced Solid Tumor decreased response detail...
FGFR3 N540K FIIN-2 Advanced Solid Tumor decreased response detail...
FGFR3 L608V LY2874455 Advanced Solid Tumor sensitive detail...
FGFR3 V555M LY2874455 Advanced Solid Tumor sensitive detail...
FGFR3 K650E LY2874455 Advanced Solid Tumor sensitive detail...
FGFR3 N540K LY2874455 Advanced Solid Tumor decreased response detail...
FGFR2 V564F Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 V564F Debio 1347 Advanced Solid Tumor sensitive detail...
FGFR2 V564F AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 V564I Debio 1347 Advanced Solid Tumor resistant detail...
FGFR2 V564L Debio 1347 Advanced Solid Tumor resistant detail...
BRAF V600E PF-00477736 + PF3644022 Advanced Solid Tumor predicted - sensitive detail...
CDKN2A loss PF-00477736 + PF3644022 Advanced Solid Tumor predicted - sensitive detail...
BRAF mutant PF-00477736 + PF3644022 Advanced Solid Tumor predicted - sensitive detail...
ALK rearrange Belizatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M Repotrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1202R Repotrectinib Advanced Solid Tumor sensitive detail...
MAP2K1 L115P CI-1040 Advanced Solid Tumor resistant detail...
MAP2K1 L115A CI-1040 Advanced Solid Tumor decreased response detail...
MAP2K1 F53S CI-1040 Advanced Solid Tumor sensitive detail...
MAP2K1 I103N CI-1040 Advanced Solid Tumor decreased response detail...
PTEN loss Everolimus Advanced Solid Tumor no benefit detail...
RET C634R RET V804M Vandetanib Advanced Solid Tumor resistant detail...
RET C634R RET Y806C Vandetanib Advanced Solid Tumor resistant detail...
RET C634R RET Y806E Vandetanib Advanced Solid Tumor resistant detail...
RET C634R RET Y806F Vandetanib Advanced Solid Tumor predicted - sensitive detail...
TP53 wild-type MK-8242 Advanced Solid Tumor unknown detail...
TP53 positive Serdemetan Advanced Solid Tumor sensitive detail...
ATM del ATR dec exp PJ34 Advanced Solid Tumor decreased response detail...
JAK3 R172Q Tofacitinib Advanced Solid Tumor sensitive detail...
JAK3 L156P Tofacitinib Advanced Solid Tumor sensitive detail...
JAK3 E183G Tofacitinib Advanced Solid Tumor sensitive detail...
JAK3 A572V Tofacitinib Advanced Solid Tumor sensitive detail...
BRAF mutant KO-947 Advanced Solid Tumor predicted - sensitive detail...
NRAS mutant KO-947 Advanced Solid Tumor predicted - sensitive detail...
BRAF mutant CC-90003 Advanced Solid Tumor no benefit detail...
NRAS mutant CC-90003 Advanced Solid Tumor no benefit detail...
TP53 wild-type ALRN-6924 Advanced Solid Tumor predicted - sensitive detail...
BRAF F247L Trametinib Advanced Solid Tumor sensitive detail...
BRAF F247L Dabrafenib Advanced Solid Tumor sensitive detail...
BRAF F595L Vemurafenib Advanced Solid Tumor resistant detail...
BRAF D594N Vemurafenib Advanced Solid Tumor predicted - resistant detail...
RAD51D S207L Olaparib Advanced Solid Tumor sensitive detail...
RAD51D S207L Talazoparib Advanced Solid Tumor sensitive detail...
JAK3 I87T JANEX-1 Advanced Solid Tumor sensitive detail...
KIT N822I Imatinib Advanced Solid Tumor resistant detail...
KIT N822I Dasatinib Advanced Solid Tumor sensitive detail...
KIT V559D Dasatinib Advanced Solid Tumor sensitive detail...
KIT V559D Imatinib Advanced Solid Tumor sensitive detail...
KIT V560D Motesanib Diphosphate Advanced Solid Tumor sensitive detail...
KIT M552_V559del Motesanib Diphosphate Advanced Solid Tumor sensitive detail...
KIT Y823D Motesanib Diphosphate Advanced Solid Tumor sensitive detail...
KIT V560D KIT V654A Motesanib Diphosphate Advanced Solid Tumor sensitive detail...
KIT V560D KIT T670I Motesanib Diphosphate Advanced Solid Tumor sensitive detail...
KIT W557_K558del Nilotinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del Dasatinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT T670I Dasatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT T670I Nilotinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT T670I Sorafenib Advanced Solid Tumor sensitive detail...
KIT V560del KIT V654A Nilotinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT D820Y Nilotinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT D820Y Dasatinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT D820Y Sorafenib Advanced Solid Tumor sensitive detail...
KIT exon17 Avapritinib Advanced Solid Tumor sensitive detail...
ALK rearrange ASP3026 Advanced Solid Tumor sensitive detail...
BRAF V600E/K PTEN loss PX-866 + Vemurafenib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198P Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198P TAE684 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N TAE684 Advanced Solid Tumor resistant detail...
HRAS G12V SR9009 Advanced Solid Tumor predicted - sensitive detail...
HRAS G12V SR9011 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 V561M PRN1371 Advanced Solid Tumor sensitive detail...
FGFR1 over exp PRN1371 Advanced Solid Tumor sensitive detail...
FGFR2 over exp PRN1371 Advanced Solid Tumor sensitive detail...
FGFR2 W290C Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 K660E Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 K660N Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 W290C Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 K660N Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 S249C Ponatinib Advanced Solid Tumor sensitive detail...
FGFR3 R248C Infigratinib Advanced Solid Tumor sensitive detail...
FGFR3 S249C Infigratinib Advanced Solid Tumor sensitive detail...
FGFR3 S249C Dovitinib Advanced Solid Tumor conflicting detail...
FGFR3 R248C Dovitinib Advanced Solid Tumor conflicting detail...
FGFR2 W290C Pazopanib Advanced Solid Tumor sensitive detail...
FGFR2 K660N Pazopanib Advanced Solid Tumor sensitive detail...
FGFR2 K660E Pazopanib Advanced Solid Tumor sensitive detail...
FGFR3 R248C Pazopanib Advanced Solid Tumor sensitive detail...
FGFR2 W290C Cediranib Advanced Solid Tumor sensitive detail...
FGFR2 K660N Cediranib Advanced Solid Tumor sensitive detail...
FGFR2 K660E Cediranib Advanced Solid Tumor sensitive detail...
FGFR2 K660E AZD4547 Advanced Solid Tumor sensitive detail...
FGFR2 K660N AZD4547 Advanced Solid Tumor sensitive detail...
FGFR2 W290C AZD4547 Advanced Solid Tumor sensitive detail...
FGFR2 K660E Lenvatinib Advanced Solid Tumor sensitive detail...
FGFR2 K660N Lenvatinib Advanced Solid Tumor sensitive detail...
FGFR2 W290C Lenvatinib Advanced Solid Tumor sensitive detail...
FGFR3 - BAIAP2L1 Derazantinib Advanced Solid Tumor sensitive detail...
FGFR2 - CIT Derazantinib Advanced Solid Tumor sensitive detail...
FGFR2 over exp Derazantinib Advanced Solid Tumor sensitive detail...
FGFR2 - CASP7 Derazantinib Advanced Solid Tumor sensitive detail...
FGFR1 over exp Derazantinib Advanced Solid Tumor sensitive detail...
KIT over exp Derazantinib Advanced Solid Tumor sensitive detail...
BRAF mutant RAF709 Advanced Solid Tumor sensitive detail...
NRAS mutant RAF709 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ALK I1171T Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK F1174C Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK F1174I Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK F1174V Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK D1203N Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK L1256F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174V ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1179V ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK L1256F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174C ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171T ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
FGFR1 amp AZD4547 Advanced Solid Tumor unknown detail...
FGFR2 amp AZD4547 Advanced Solid Tumor unknown detail...
ROS1 fusion Repotrectinib Advanced Solid Tumor predicted - sensitive detail...
ROS1 fusion ROS1 G2032R Repotrectinib Advanced Solid Tumor predicted - sensitive detail...
ALK fusion Repotrectinib Advanced Solid Tumor predicted - sensitive detail...
MAP2K1 F53L Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 Q56P Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 K57N Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 C121S Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 F129L Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 I111S Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 V211D Selumetinib Advanced Solid Tumor resistant detail...
MAP2K1 V211D PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 F53L PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 K57N PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 I111S PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 C121S PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 F129L PLX4720 Advanced Solid Tumor sensitive detail...
MAP2K1 V211D PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 F53L PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 Q56P PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 K57N PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 I111S PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 C121S PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 F129L PD98059 Advanced Solid Tumor resistant detail...
MAP2K1 V211D Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 F53L Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 Q56P Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 K57N Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 I111S Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 C121S Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 F129L Regorafenib Advanced Solid Tumor resistant detail...
MAP2K1 V211D GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 F53L GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 Q56P GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 K57N GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 I111S GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 C121S GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 F129L GDC0879 Advanced Solid Tumor resistant detail...
MAP2K1 V211D AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 F53L AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 Q56P AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 K57N AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 I111S AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 C121S AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 F129L AZD8330 Advanced Solid Tumor resistant detail...
MAP2K1 Q56P PLX4720 Advanced Solid Tumor sensitive detail...
KIT V559D Flumatinib Advanced Solid Tumor sensitive detail...
KIT V559D Sunitinib Advanced Solid Tumor sensitive detail...
KIT V559_V560del Sunitinib Advanced Solid Tumor sensitive detail...
KIT V559_V560del Imatinib Advanced Solid Tumor sensitive detail...
KIT V559_V560del Flumatinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Imatinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Flumatinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Sunitinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT V654A Sunitinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT T670I Sunitinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT N822K Sunitinib Advanced Solid Tumor no benefit detail...
KIT V559D KIT Y823D Sunitinib Advanced Solid Tumor no benefit detail...
KIT V559D KIT A829P Sunitinib Advanced Solid Tumor no benefit detail...
KIT V560D KIT V654A Flumatinib Advanced Solid Tumor resistant detail...
KIT V560D KIT T670I Flumatinib Advanced Solid Tumor resistant detail...
KIT V559D KIT D820G Flumatinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT N822K Flumatinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT Y823D Flumatinib Advanced Solid Tumor sensitive detail...
KIT I571_D579dup Sunitinib Advanced Solid Tumor predicted - resistant detail...
KIT V559D KIT A829P Flumatinib Advanced Solid Tumor sensitive detail...
KIT I571_D579dup Imatinib Advanced Solid Tumor predicted - resistant detail...
KIT I571_D579dup Flumatinib Advanced Solid Tumor predicted - resistant detail...
KIT V559D KIT Y823D Imatinib Advanced Solid Tumor no benefit detail...
KIT D816V Flumatinib Advanced Solid Tumor resistant detail...
KIT D816Y Flumatinib Advanced Solid Tumor resistant detail...
KIT D816Y Sunitinib Advanced Solid Tumor resistant detail...
KIT D816Y Imatinib Advanced Solid Tumor resistant detail...
KIT D816H Flumatinib Advanced Solid Tumor predicted - sensitive detail...
KIT D816H Sunitinib Advanced Solid Tumor predicted - sensitive detail...
KIT N822K Imatinib Advanced Solid Tumor resistant detail...
KIT N822K Flumatinib Advanced Solid Tumor predicted - sensitive detail...
KIT N822K Sunitinib Advanced Solid Tumor predicted - sensitive detail...
KIT T417_D419delinsI Flumatinib Advanced Solid Tumor sensitive detail...
KIT T417_D419delinsI Sunitinib Advanced Solid Tumor sensitive detail...
RET M918T Selpercatinib Advanced Solid Tumor sensitive detail...
CSF3R T618I Ibrutinib Advanced Solid Tumor sensitive detail...
CSF3R Q741* Ibrutinib Advanced Solid Tumor sensitive detail...
CSF3R Q741* Ruxolitinib Advanced Solid Tumor sensitive detail...
CSF3R T618I Ibrutinib + Ruxolitinib Advanced Solid Tumor sensitive detail...
CSF3R Q741* Ibrutinib + Ruxolitinib Advanced Solid Tumor sensitive detail...
KIT D816F Imatinib Advanced Solid Tumor resistant detail...
EML4 - ALK Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK Ensartinib Advanced Solid Tumor sensitive detail...
EML4 - NTRK3 Entrectinib Advanced Solid Tumor predicted - sensitive detail...
CSF3R N610H Ruxolitinib Advanced Solid Tumor sensitive detail...
CSF3R N610S Ruxolitinib Advanced Solid Tumor sensitive detail...
CSF3R N610S Trametinib Advanced Solid Tumor predicted - sensitive detail...
CSF3R N610H Trametinib Advanced Solid Tumor predicted - sensitive detail...
BRAF V600E Vemurafenib Advanced Solid Tumor sensitive detail...
BRAF G596R Vemurafenib Advanced Solid Tumor no benefit detail...
BRAF N581S Vemurafenib Advanced Solid Tumor no benefit detail...
BRAF G466V Vemurafenib Advanced Solid Tumor no benefit detail...
BRAF G606E Vemurafenib Advanced Solid Tumor no benefit detail...
BRAF P731T Vemurafenib Advanced Solid Tumor no benefit detail...
EML4 - ALK Repotrectinib Advanced Solid Tumor sensitive detail...
BRAF N486_T491delinsK Cobimetinib Advanced Solid Tumor predicted - sensitive detail...
TP53 mutant Unspecified VEGFR inhibitor Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D816H AZD3229 Advanced Solid Tumor sensitive detail...
EML4 - ALK WX-0593 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M WX-0593 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y WX-0593 Advanced Solid Tumor sensitive detail...
FGFR1 amp Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 amp Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 amp Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 fusion Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 fusion Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 fusion Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 mutant Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 mutant Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 mutant Debio 1347 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 - BAIAP2L1 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - BICC1 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - AFF3 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - CASP7 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - CCDC6 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - OFD1 Erdafitinib Advanced Solid Tumor sensitive detail...
ATM negative BAY1895344 Advanced Solid Tumor predicted - sensitive detail...
ATM inact mut BAY1895344 Advanced Solid Tumor predicted - sensitive detail...
BRAF mutant LXH 254 Advanced Solid Tumor predicted - sensitive detail...
MAP2K1 V211D Binimetinib Advanced Solid Tumor predicted - resistant detail...
MAP2K1 V211D Cobimetinib Advanced Solid Tumor predicted - resistant detail...
BRAF V504_R506dup Sorafenib Advanced Solid Tumor resistant detail...
BRAF V504_R506dup Vemurafenib Advanced Solid Tumor resistant detail...
BRAF V504_R506dup Trametinib Advanced Solid Tumor resistant detail...
KIT L576P Axitinib Advanced Solid Tumor sensitive detail...
KIT V559D Axitinib Advanced Solid Tumor sensitive detail...
KIT V559A Axitinib Advanced Solid Tumor sensitive detail...
KIT V559G Axitinib Advanced Solid Tumor sensitive detail...
KIT V654A Axitinib Advanced Solid Tumor sensitive detail...
KIT V559D KIT V654A Axitinib Advanced Solid Tumor sensitive detail...
KIT T670I Axitinib Advanced Solid Tumor sensitive detail...
KIT A829P Axitinib Advanced Solid Tumor sensitive detail...
KIT V654A Sunitinib Advanced Solid Tumor sensitive detail...
KIT T670I Sunitinib Advanced Solid Tumor sensitive detail...
BRAF mut TP53 wild-type Pimasertib + SAR405838 Advanced Solid Tumor predicted - sensitive detail...
NRAS mut TP53 wild-type Pimasertib + SAR405838 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK S1206Y Alectinib Advanced Solid Tumor conflicting detail...
EML4 - ALK ALK T1151dup Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1152R ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1152R Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ASP3026 Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1202R ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK S1206Y ASP3026 Advanced Solid Tumor resistant detail...
EML4 - ALK ALK S1206Y Crizotinib Advanced Solid Tumor resistant detail...
PIK3CA H1047R Alpelisib Advanced Solid Tumor predicted - sensitive detail...
KIT V654A KIT D816V Midostaurin Advanced Solid Tumor resistant detail...
KIT T670I KIT D816V Midostaurin Advanced Solid Tumor decreased response detail...
KIT N655K KIT D816V Midostaurin Advanced Solid Tumor resistant detail...
KIT Y672C KIT D816V Midostaurin Advanced Solid Tumor decreased response detail...
KIT D677N KIT D816V Midostaurin Advanced Solid Tumor resistant detail...
KIT D816V Midostaurin Advanced Solid Tumor sensitive detail...
KIT D816V Avapritinib Advanced Solid Tumor sensitive detail...
KIT V654A KIT D816V Avapritinib Advanced Solid Tumor predicted - sensitive detail...
KIT N655K KIT D816V Avapritinib Advanced Solid Tumor predicted - sensitive detail...
KIT Y672C KIT D816V Avapritinib Advanced Solid Tumor predicted - sensitive detail...
KIT D677N KIT D816V Avapritinib Advanced Solid Tumor predicted - sensitive detail...
KIT T670I KIT D816V Avapritinib Advanced Solid Tumor resistant detail...
KIT T670A KIT D816V Avapritinib Advanced Solid Tumor sensitive detail...
KIT T670V KIT D816V Avapritinib Advanced Solid Tumor predicted - resistant detail...
KIT T670A KIT D816V Midostaurin Advanced Solid Tumor sensitive detail...
KIT T670V KIT D816V Midostaurin Advanced Solid Tumor sensitive detail...
KIT V560D KIT V654A Avapritinib Advanced Solid Tumor decreased response detail...
KIT D816V Ripretinib Advanced Solid Tumor sensitive detail...
KIT D816V Regorafenib Advanced Solid Tumor resistant detail...
PIK3CA mutant Alpelisib + Infigratinib Advanced Solid Tumor no benefit detail...
HRAS G12V WM-8014 Advanced Solid Tumor sensitive detail...
FGFR2 - PPHLN1 Infigratinib Advanced Solid Tumor sensitive detail...
SMARCB1 negative Tazemetostat Advanced Solid Tumor predicted - sensitive detail...
SMARCA4 negative Tazemetostat Advanced Solid Tumor predicted - sensitive detail...
BRAF V600X Dabrafenib Advanced Solid Tumor predicted - sensitive detail...
FLT3 exon 14 ins LAM-003 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 F691L LAM-003 Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins Crenolanib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y ALK G1269A Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK G1269A Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK C1156Y ALK G1269A Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174L ALK G1202R Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Lorlatinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 E565A Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 L617M Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 AZD4547 Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 Futibatinib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 E565A AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 E565A Erdafitinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 E565A Futibatinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 E565A Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 E565A Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 L617M AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 L617M Erdafitinib Advanced Solid Tumor resistant detail...
FGFR2 - SHTN1 FGFR2 L617M Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 E565A FGFR2 L617M Infigratinib + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 E565A AZD4547 + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 E565A Erdafitinib + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 E565A Ponatinib + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 L617M Ponatinib + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 L617M Erdafitinib + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 L617M AZD4547 + Sapanisertib Advanced Solid Tumor sensitive detail...
FGFR2 - SHTN1 FGFR2 L617M Infigratinib + Sapanisertib Advanced Solid Tumor sensitive detail...
JAK2 V617F JAK2 R971G Ruxolitinib Advanced Solid Tumor resistant detail...
JAK2 V617F JAK2 L983F Ruxolitinib Advanced Solid Tumor resistant detail...
JAK2 V617F JAK2 E987D Ruxolitinib Advanced Solid Tumor resistant detail...
TP53 R181E Nutlin-3a Advanced Solid Tumor no benefit detail...
TP53 R181E Doxorubicin + Nutlin-3a Advanced Solid Tumor sensitive detail...
TP53 R181E Doxorubicin + SAR405838 Advanced Solid Tumor sensitive detail...
TP53 R181E Doxorubicin + Idasanutlin Advanced Solid Tumor sensitive detail...
TP53 R181E Doxorubicin + RG7112 Advanced Solid Tumor sensitive detail...
JAK2 V617F JAK2 Y931C Fedratinib Advanced Solid Tumor sensitive detail...
JAK2 V617F JAK2 Y931C JAK2 S1025C Fedratinib Advanced Solid Tumor resistant detail...
JAK2 V617F JAK2 Y931C JAK2 Y1045W Fedratinib Advanced Solid Tumor resistant detail...
JAK2 V617F JAK2 Y931C JAK2 F1061W Fedratinib Advanced Solid Tumor resistant detail...
JAK2 V617F JAK2 Y931C JAK2 V1075F Fedratinib Advanced Solid Tumor resistant detail...
BRAF mutant LY3009120 Advanced Solid Tumor no benefit detail...
NRAS mutant LY3009120 Advanced Solid Tumor no benefit detail...
EML4 - ALK DS6051b Advanced Solid Tumor sensitive detail...
FGFR2 - TACC3 Ganetespib + Infigratinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171S ALK G1269A Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK G1269A Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK G1269A Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK G1269A Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171S ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
RET R886W Sorafenib Advanced Solid Tumor sensitive detail...
BRAF mutant Trametinib Advanced Solid Tumor no benefit detail...
BRAF G466V Trametinib Advanced Solid Tumor no benefit detail...
FGFR2 - TACC3 Ganetespib Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 FGFR2 N549H Pemigatinib Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 FGFR2 N549H Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 FGFR2 N549H AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 FGFR2 N549H Erdafitinib Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 FGFR2 N549H Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 - CLIP1 Pemigatinib Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 AZD4547 Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 Ponatinib Advanced Solid Tumor sensitive detail...
FGFR2 - CLIP1 FGFR2 N549H Ponatinib Advanced Solid Tumor sensitive detail...
PIK3CA mutant Copanlisib Advanced Solid Tumor predicted - sensitive detail...
RET fusion Pralsetinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 act mut AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 act mut AZD4547 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK G1202R TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198F TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK I1171N TPX-0131 Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK I1171S TPX-0131 Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK I1171T TPX-0131 Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK G1269S TPX-0131 Advanced Solid Tumor decreased response detail...
EML4 - ALK ALK G1269A TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1196M ALK L1198F TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK C1156Y ALK L1198F TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK C1156Y ALK G1202R TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1196M ALK G1202R TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198F ALK G1202R TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK G1202R ALK G1269A TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK G1202R ALK L1204V ALK G1269A TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198F ALK G1202R ALK G1269A TPX-0131 Advanced Solid Tumor predicted - sensitive detail...
KIT C809G Imatinib Advanced Solid Tumor predicted - resistant detail...
MAP2K1 E41_L54del Trametinib Advanced Solid Tumor sensitive detail...
MAP2K1 E41_L54del Selumetinib Advanced Solid Tumor sensitive detail...
MAP2K1 E41_L54del Cobimetinib Advanced Solid Tumor sensitive detail...
MAP2K1 E41_L54del LY3009120 Advanced Solid Tumor no benefit detail...
JAK3 T1022I Tofacitinib Advanced Solid Tumor sensitive detail...
FLT3 exon 14 ins FLT3 D698N Gilteritinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N676T Quizartinib Advanced Solid Tumor resistant detail...
FLT3 exon 14 ins FLT3 N676T Midostaurin Advanced Solid Tumor resistant detail...
ATM inact mut Radiotherapy Advanced Solid Tumor predicted - sensitive detail...
BRAF V600X BGB-283 Advanced Solid Tumor predicted - sensitive detail...
KIT W557_K558del KIT V654A AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT V654A Avapritinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT V654A Ripretinib Advanced Solid Tumor resistant detail...
KIT V560D AZD3229 Advanced Solid Tumor sensitive detail...
KIT V560D Avapritinib Advanced Solid Tumor sensitive detail...
KIT V560D Ripretinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup AZD3229 Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Regorafenib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Avapritinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del Avapritinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT T670I AZD3229 Advanced Solid Tumor sensitive detail...
KIT V560D KIT V654A AZD3229 Advanced Solid Tumor sensitive detail...
KIT V560D KIT V654A Sunitinib Advanced Solid Tumor sensitive detail...
KIT V560D KIT V654A Imatinib Advanced Solid Tumor resistant detail...
KIT V560D KIT V654A Regorafenib Advanced Solid Tumor resistant detail...
KIT V560D KIT V654A Ripretinib Advanced Solid Tumor decreased response detail...
KIT A502_Y503dup KIT V654A AZD3229 Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup KIT V654A Sunitinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup KIT V654A Imatinib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT V654A Regorafenib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT V654A Avapritinib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT V654A Ripretinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT T670I Avapritinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT T670I Ripretinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT D816H Avapritinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D816H Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT N822K AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT N822K Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT N822K Avapritinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D820A Avapritinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D820A Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT D820A AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT Y823D Ripretinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT Y823D Regorafenib Advanced Solid Tumor predicted - sensitive detail...
KIT W557_K558del KIT Y823D Avapritinib Advanced Solid Tumor decreased response detail...
KIT W557_K558del KIT Y823D Sunitinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT Y823D Imatinib Advanced Solid Tumor resistant detail...
KIT W557_K558del KIT Y823D AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT A829P AZD3229 Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT A829P Ripretinib Advanced Solid Tumor sensitive detail...
KIT W557_K558del KIT A829P Avapritinib Advanced Solid Tumor sensitive detail...
KIT V560D KIT D816H AZD3229 Advanced Solid Tumor sensitive detail...
KIT V560D KIT D816H Imatinib Advanced Solid Tumor resistant detail...
KIT V560D KIT D816H Sunitinib Advanced Solid Tumor resistant detail...
KIT V560D KIT D816H Regorafenib Advanced Solid Tumor resistant detail...
KIT V560D KIT D820A Avapritinib Advanced Solid Tumor decreased response detail...
KIT V560D KIT D816H Avapritinib Advanced Solid Tumor decreased response detail...
KIT V560D KIT D816H Ripretinib Advanced Solid Tumor sensitive detail...
KIT V560D KIT D820A Ripretinib Advanced Solid Tumor sensitive detail...
KIT V560D KIT D820A AZD3229 Advanced Solid Tumor sensitive detail...
KIT V560D KIT D820A Imatinib Advanced Solid Tumor resistant detail...
KIT V560D KIT D820A Sunitinib Advanced Solid Tumor resistant detail...
KIT V560D KIT D820A Regorafenib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup KIT D816H Imatinib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT D816H Sunitinib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT D816H Regorafenib Advanced Solid Tumor resistant detail...
KIT A502_Y503dup KIT D816H AZD3229 Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup KIT D816H Avapritinib Advanced Solid Tumor sensitive detail...
KIT A502_Y503dup KIT D816H Ripretinib Advanced Solid Tumor decreased response detail...
FGFR1 over exp Rogaratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 over exp Rogaratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 over exp Rogaratinib Advanced Solid Tumor predicted - sensitive detail...
IDH1 R132L DS-1001b Advanced Solid Tumor predicted - sensitive detail...
IDH1 R132G DS-1001b Advanced Solid Tumor predicted - sensitive detail...
IDH1 R132S DS-1001b Advanced Solid Tumor predicted - sensitive detail...
IDH1 R132C DS-1001b Advanced Solid Tumor predicted - sensitive detail...
IDH1 R132H DS-1001b Advanced Solid Tumor predicted - sensitive detail...
HRAS G12V HRAS R135K NS1 Advanced Solid Tumor resistant detail...
HRAS G12V HRAS R135A NS1 Advanced Solid Tumor resistant detail...
KIT wild-type PLX9486 Advanced Solid Tumor sensitive detail...
KIT D816V PLX9486 Advanced Solid Tumor sensitive detail...
KIT V560G KIT D816V Imatinib Advanced Solid Tumor resistant detail...
KIT V560G KIT D816V PLX9486 Advanced Solid Tumor sensitive detail...
PIK3CA act mut Palbociclib + Taselisib Advanced Solid Tumor predicted - sensitive detail...
KIT W557_K558del Cabozantinib Advanced Solid Tumor sensitive detail...
KIT T670I Regorafenib Advanced Solid Tumor sensitive detail...
KIT T670I Cabozantinib Advanced Solid Tumor sensitive detail...
KIT N655K Imatinib Advanced Solid Tumor predicted - sensitive detail...
KIT N655K Sunitinib Advanced Solid Tumor decreased response detail...
KIT N655K Regorafenib Advanced Solid Tumor decreased response detail...
KIT N655K Cabozantinib Advanced Solid Tumor decreased response detail...
KIT N655K Avapritinib Advanced Solid Tumor predicted - sensitive detail...
KIT N655K Ripretinib Advanced Solid Tumor predicted - sensitive detail...
KIT T670I Imatinib Advanced Solid Tumor resistant detail...
BRAF V600E Trametinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 fusion Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 amp Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 amp Futibatinib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK Entrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171T Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171T Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171S Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK C1156Y Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Entrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK T1151K Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK V1180L Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Entrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK V1180L Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK F1174V Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174V Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174V Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174I Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174V Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1174V Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1174I Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1198F Entrectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196Q Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196Q Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196Q Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196Q Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196Q Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196Q Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196Q Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1202R Gilteritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N Gilteritinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK F1245V Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1245V Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1245V Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1245V Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1245V Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK F1245V Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK F1245V Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1256F Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1256F Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1256F Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1256F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1256F Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1256F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1256F Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK G1269A Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK F1174I Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174I Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK F1174L Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK F1174L Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK F1174L Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174L Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK F1174L Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK F1174L Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N ALK F1174L Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1198H Crizotinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Crizotinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1198F Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198H Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198H Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Brigatinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N ALK L1198H Brigatinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Entrectinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK I1171N ALK L1198H Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198H Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1198F Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1198H Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1196M Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1196M Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1196M Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1196M Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1196M Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1196M Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1196M Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK G1269A Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK G1269A Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK G1269A Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK G1269A Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171S ALK G1269A Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK G1269A Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK G1269A Ceritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK G1269A Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1256F Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1256F Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1256F Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1256F Lorlatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1256F Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK I1171N ALK L1256F Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK I1171N ALK L1256F Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M ALK G1202R Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Gilteritinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Brigatinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK G1202R Ceritinib Advanced Solid Tumor resistant detail...
RET over exp Cabozantinib Advanced Solid Tumor predicted - sensitive detail...
EML4 - ALK ALK L1198F ALK G1202R Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1198F ALK G1202R Gilteritinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK L1196M ALK D1203N Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Brigatinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Gilteritinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Alectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK L1196M ALK D1203N Ceritinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N ALK F1245V Ceritinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK D1203N ALK F1245V Lorlatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N ALK F1245V Entrectinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK D1203N ALK F1245V Gilteritinib Advanced Solid Tumor predicted - resistant detail...
EML4 - ALK ALK D1203N ALK F1245V Alectinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N ALK F1245V Brigatinib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK D1203N ALK F1245V Crizotinib Advanced Solid Tumor resistant detail...
PTEN mutant Talazoparib Advanced Solid Tumor no benefit detail...
PIK3CA act mut TAS-117 Advanced Solid Tumor no benefit detail...
PIK3CA act mut LY3023414 + Prexasertib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 mutant ICP-192 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 mutant ICP-192 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 mutant ICP-192 Advanced Solid Tumor predicted - sensitive detail...
TP53 Y220C PC14586 Advanced Solid Tumor predicted - sensitive detail...
TSC1 inact mut Nab-rapamycin Advanced Solid Tumor predicted - sensitive detail...
TSC2 inact mut Nab-rapamycin Advanced Solid Tumor predicted - sensitive detail...
BRAF mutant Binimetinib + Encorafenib Advanced Solid Tumor predicted - sensitive detail...
MLH1 negative Dostarlimab-gxly Advanced Solid Tumor predicted - sensitive detail...
MSH6 negative Dostarlimab-gxly Advanced Solid Tumor predicted - sensitive detail...
NRAS act mut Selumetinib Advanced Solid Tumor no benefit detail...
HRAS act mut Selumetinib Advanced Solid Tumor no benefit detail...
BRAF V600E Selumetinib Advanced Solid Tumor no benefit detail...
RET V804M RET M918T Selpercatinib Advanced Solid Tumor sensitive detail...
RET V804M RET G810C RET M918T Selpercatinib Advanced Solid Tumor resistant detail...
RET V804M RET G810S RET M918T Selpercatinib Advanced Solid Tumor resistant detail...
NRAS G12X Binimetinib Advanced Solid Tumor no benefit detail...
NRAS G13X Binimetinib Advanced Solid Tumor no benefit detail...
NRAS Q61X Binimetinib Advanced Solid Tumor unknown detail...
RB1 positive SHR6390 Advanced Solid Tumor sensitive detail...
RB1 dec exp SHR6390 Advanced Solid Tumor no benefit detail...
NRAS Q61R Belvarafenib Advanced Solid Tumor sensitive detail...
EML4 - ALK ALK G1269S Crizotinib Advanced Solid Tumor resistant detail...
EML4 - ALK ALK S1206R Crizotinib Advanced Solid Tumor resistant detail...
FGFR2 N549H E7090 Advanced Solid Tumor sensitive detail...
FGFR2 N549H Futibatinib Advanced Solid Tumor sensitive detail...
FGFR2 N549K AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 N549K Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 N549K Erdafitinib Advanced Solid Tumor resistant detail...
FGFR2 N549K Pemigatinib Advanced Solid Tumor resistant detail...
FGFR2 N549K E7090 Advanced Solid Tumor conflicting detail...
FGFR2 N549D AZD4547 Advanced Solid Tumor resistant detail...
FGFR2 N549D Infigratinib Advanced Solid Tumor resistant detail...
FGFR2 N549D Erdafitinib Advanced Solid Tumor resistant detail...
FGFR2 N549D Futibatinib Advanced Solid Tumor sensitive detail...
FGFR2 N549D Pemigatinib Advanced Solid Tumor resistant detail...
FGFR3 K650N Infigratinib Advanced Solid Tumor sensitive detail...
FGFR3 K650N E7090 Advanced Solid Tumor resistant detail...
FGFR3 K650N Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR3 K650N Futibatinib Advanced Solid Tumor sensitive detail...
FGFR3 K650N Pemigatinib Advanced Solid Tumor sensitive detail...
FGFR2 N549K Dovitinib Advanced Solid Tumor resistant detail...
FGFR2 N549D Dovitinib Advanced Solid Tumor resistant detail...
FGFR3 K650T Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 K650M Dovitinib Advanced Solid Tumor resistant detail...
FGFR3 K650M AZD4547 Advanced Solid Tumor resistant detail...
FGFR1 N546K AZD4547 Advanced Solid Tumor predicted - resistant detail...
FGFR1 N546K Infigratinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 N546K Erdafitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 N546K Futibatinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 N546K Pemigatinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 N546K Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 N549S Infigratinib Advanced Solid Tumor sensitive detail...
FGFR2 N549S E7090 Advanced Solid Tumor sensitive detail...
FGFR2 N549S Erdafitinib Advanced Solid Tumor sensitive detail...
FGFR2 N549S Futibatinib Advanced Solid Tumor sensitive detail...
FGFR2 N549S Pemigatinib Advanced Solid Tumor sensitive detail...
FGFR2 N549S Dovitinib Advanced Solid Tumor resistant detail...
FGFR1 - TACC1 AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 - TACC1 Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 - TACC1 Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 - TACC1 Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 K656E Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 K656E Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 K656E Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 K656E Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 K656M AZD4547 Advanced Solid Tumor predicted - resistant detail...
FGFR1 K656M E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR1 K656M Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 - AHCYL1 Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 - AHCYL1 Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - AHCYL1 Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - AHCYL1 Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - AHCYL1 E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - AHCYL1 AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - CCDC6 Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - CCDC6 Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - CCDC6 Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - CCDC6 Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 - SHTN1 Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - SHTN1 E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - SHTN1 Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 - PPHLN1 Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 S252W Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 S252W Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 S252W Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 S252W E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 S252W Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 S252W AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 Y375C Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 C382R AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 C382R Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 C382R Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 C382R Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 C382R Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 C382R Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 K659E Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659E Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659E Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659E Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 K659N Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR2 K659N Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659N Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659N Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659N E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659N Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR2 K659N AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 - TACC3 Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 - TACC3 Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 S249C E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR3 G370C Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 G370C E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR3 G370C Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 S371C Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 S371C E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR3 S371C Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 Y373C Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 Y373C E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR3 Y373C Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 G380R Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 G380R Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 G380R Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 G380R Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR3 A391E Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 A391E AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR3 A391E Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 A391E Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR3 A391E Dovitinib Advanced Solid Tumor predicted - resistant detail...
BRAF L485_P490del Vemurafenib Advanced Solid Tumor predicted - resistant detail...
BRAF L485_P490del LY3009120 Advanced Solid Tumor predicted - sensitive detail...
FGFR2 V564M Infigratinib Advanced Solid Tumor resistant detail...
MLH1 negative Pembrolizumab Advanced Solid Tumor sensitive detail...
MSH6 negative Pembrolizumab Advanced Solid Tumor sensitive detail...
FGFR1 S125L AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S125L Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 T141R AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T141R Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T141R E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T141R Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T141R Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T141R Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 P150S Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 P150S E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 P150S Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 P150S AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R250W Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A268S Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A268S Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A268S E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR1 A268S Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A268S AZD4547 Advanced Solid Tumor predicted - sensitive detail...
MAP2K1 L98_K104delinsQ Trametinib Advanced Solid Tumor resistant detail...
MAP2K1 L98_K104delinsQ MK2206 Advanced Solid Tumor resistant detail...
MAP2K1 L98_K104delinsQ U0126 Advanced Solid Tumor resistant detail...
MAP2K1 L98_K104delinsQ SCH772984 Advanced Solid Tumor resistant detail...
FGFR1 A21T AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A21T Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A21T E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A21T Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A21T Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A21T Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I Dovitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T26I AZD4547 Advanced Solid Tumor predicted - resistant detail...
FGFR1 A121D AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 A121D Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 D128N AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128N Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128N E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128N Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128N Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D128V AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 D133N Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R189C AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R189C Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 R189C Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 S238N Dovitinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 S238N Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S238N Futibatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S238N Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S238N E7090 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 S238N Infigratinib Advanced Solid Tumor predicted - resistant detail...
FGFR1 S238N AZD4547 Advanced Solid Tumor predicted - resistant detail...
FGFR1 T319A AZD4547 Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T319A Infigratinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T319A E7090 Advanced Solid Tumor predicted - resistant detail...
FGFR1 T319A Erdafitinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T319A Pemigatinib Advanced Solid Tumor predicted - sensitive detail...
FGFR1 T319A Dovitinib Advanced Solid Tumor predicted - resistant detail...
Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT00006199 Phase I Tipifarnib Topotecan Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32) Unknown status USA 0
NCT00084695 Phase II Fludarabine Busulfan + Melphalan anti-thymocyte globulin Cyclophosphamide Prednisone Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Unknown status USA 0
NCT00089245 Phase I Omburtamab I-131 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer Active, not recruiting USA 0
NCT00313599 Phase I Lapatinib + Paclitaxel Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Completed USA 0
NCT00463060 Phase Ib/II Sunitinib Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer Completed USA 0
NCT00576654 Phase I Irinotecan Veliparib Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery Active, not recruiting USA 0
NCT00585195 Phase I Crizotinib + Itraconazole Crizotinib + Rifampin A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001) Active, not recruiting USA 3
NCT00608361 Phase I Dasatinib Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery Completed USA 0
NCT00610948 Phase I Everolimus Panitumumab Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment Completed USA 0
NCT00625378 Phase III Sorafenib Sorafenib Long Term Extension Program (STEP) Completed USA | CAN 17
NCT00658658 Phase I Panitumumab Panitumumab Pediatric Study Completed USA 0
NCT00665990 Phase I Bevacizumab + Cyclophosphamide + Sorafenib Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia Completed USA 0
NCT00697632 Phase I Glesatinib Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies Completed USA | CAN 1
NCT00740805 Phase I Aldoxorubicin + Cyclophosphamide + Veliparib Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma Active, not recruiting USA 0
NCT00756340 Phase I Bevacizumab + Everolimus A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors Completed USA 0
NCT00761644 Phase I Bevacizumab + Pegylated liposomal-doxorubicin + Temsirolimus Doxil, Bevacizumab and Temsirolimus Trial Completed USA 0
NCT00770263 Phase I Erlotinib + Temsirolimus Erlotinib and Temsirolimus for Solid Tumors Completed USA 0
NCT00776867 Phase I Perifosine Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors Completed USA 0
NCT00781612 Phase II Ado-trastuzumab emtansine + Trastuzumab Ado-trastuzumab emtansine + Paclitaxel Ado-trastuzumab emtansine Ado-trastuzumab emtansine + Docetaxel Ado-trastuzumab emtansine + Capecitabine Ado-trastuzumab emtansine + Pertuzumab A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies Recruiting USA | CAN 37
NCT00790816 Phase I Lapatinib + Paclitaxel Lapatinib Lapatinib + Trastuzumab Capecitabine + Lapatinib Lapatinib + Letrozole Capecitabine + Lapatinib + Oxaliplatin Gemcitabine + Lapatinib Docetaxel + Lapatinib Fluorouracil + Lapatinib + Leucovorin + Oxaliplatin Fluorouracil + Irinotecan + Lapatinib + Leucovorin Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents Completed USA | CAN 3
NCT00854152 Phase I GDC-0980 A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma Completed USA 1
NCT00858377 Phase I AMG 900 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Completed USA 1
NCT00889954 Phase I Autologous TGF beta resistant HER2 EBV CTLs Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy Completed USA 0
NCT00909831 Phase I Hydroxychloroquine + Temsirolimus Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment Completed USA 0
NCT00926640 Phase I Belinostat + Cisplatin + Etoposide A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers Completed USA 0
NCT00939770 Phase Ib/II Crizotinib Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Completed USA | CAN 0
NCT00940381 Phase I Cetuximab + Sirolimus Sirolimus and Cetuximab in Advanced Malignancies Completed USA 0
NCT00981890 Phase I Sunitinib Stereotactic Radiosurgery With Sunitinib for Brain Metastases Active, not recruiting CAN 0
NCT00996892 Phase I Cobimetinib + Pictilisib Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors Terminated USA 0
NCT00999401 Phase I Sapacitabine + Seliciclib A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors Unknown status USA 0
NCT01004224 Phase I Infigratinib A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Completed USA 13
NCT01004861 Phase I Pexidartinib Safety Study of PLX108-01 in Patients With Solid Tumors Completed USA 0
NCT01012817 Phase Ib/II Topotecan + Veliparib Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer Active, not recruiting USA 0
NCT01014936 Phase I Tepotinib First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors Completed USA 0
NCT01015222 Phase I Methylnaltrexone Bromide Dasatinib Paclitaxel Bevacizumab Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies Active, not recruiting USA 0
NCT01017640 Phase I Veliparib Mitomycin C + Veliparib Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors Completed USA 0
NCT01023737 Phase I Hydroxychloroquine + Vorinostat Hydroxychloroquine + Vorinostat in Advanced Solid Tumors Active, not recruiting USA 0
NCT01037790 Phase II Palbociclib PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Completed USA 0
NCT01042535 Phase Ib/II Ad.p53-DC vaccine + Indoximod Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer Completed USA 0
NCT01058707 Phase I Sapanisertib Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies Completed USA 1
NCT01061788 Phase I Everolimus + Ganitumab + Panitumumab A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer Completed USA 0
NCT01063075 Phase II Carboplatin + Cetuximab + Fluorouracil A Study in Advanced Solid Tumors Completed USA | CAN 0
NCT01071941 Phase I Oncolytic HSV-1 rRp450 rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors Recruiting USA 0
NCT01081808 Phase I EGFRBi-armed autologous activated T cells Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors Terminated USA 0
NCT01087554 Phase I Temsirolimus Everolimus Sirolimus Vorinostat Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer Active, not recruiting USA 0
NCT01087983 Phase I Lapatinib + Sirolimus Lapatinib + Metformin Lapatinib With Sirolimus or Metformin Completed USA 0
NCT01099358 Phase II Cetuximab + Cisplatin Fluorouracil Study in Advanced Solid Tumors Completed USA | CAN 0
NCT01106599 Phase I GDC-0623 A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors Completed USA 0
NCT01107522 Phase I Carboxyamidotriazole Orotate + Temozolomide Carboxyamidotriazole Orotate Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas Unknown status USA 0
NCT01113476 Phase I Bevacizumab + Gemcitabine + Nab-paclitaxel Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies Unknown status USA 0
NCT01121588 Phase I Crizotinib An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK) Active, not recruiting USA 6
NCT01122199 Phase I Everolimus + Ganitumab Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors Completed USA 0
NCT01138085 Phase I Trametinib + Uprosertib Safety, Pharmacokinetics (PK) of AKT and MEK Combination Completed USA 0
NCT01139723 Phase I Bevacizumab MINT1526A A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors Completed USA 0